These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12549670)

  • 1. An overview of the diversity represented in commercially-available databases.
    Bradley MP
    Mol Divers; 2002; 5(4):175-83. PubMed ID: 12549670
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular diversity in chemical databases: comparison of medicinal chemistry knowledge bases and databases of commercially available compounds.
    Cummins DJ; Andrews CW; Bentley JA; Cory M
    J Chem Inf Comput Sci; 1996; 36(4):750-63. PubMed ID: 8768767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the diversity represented in commercially-available databases.
    Bradley MP
    J Comput Aided Mol Des; 2002; 16(5-6):301-9. PubMed ID: 12489680
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method to improve the odds in finding 'lead-like' compounds from chemical libraries.
    Horio K; Muta H; Goto J; Hirayama N
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):980-4. PubMed ID: 17603185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse viewpoints on computational aspects of molecular diversity.
    Martin YC
    J Comb Chem; 2001; 3(3):231-50. PubMed ID: 11350246
    [No Abstract]   [Full Text] [Related]  

  • 8. IDMap: facilitating the detection of potential leads with therapeutic targets.
    Ha S; Seo YJ; Kwon MS; Chang BH; Han CK; Yoon JH
    Bioinformatics; 2008 Jun; 24(11):1413-5. PubMed ID: 18417489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning for virtual screening (part 1).
    Ivanciuc O
    Comb Chem High Throughput Screen; 2009 May; 12(4):330-1. PubMed ID: 19442062
    [No Abstract]   [Full Text] [Related]  

  • 10. Random molecular fragment methods in computational medicinal chemistry.
    Lounkine E; Batista J; Bajorath J
    Curr Med Chem; 2008; 15(21):2108-21. PubMed ID: 18781938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the utility of molecular scaffolds for medicinal and computational chemistry.
    Bajorath J
    Future Med Chem; 2018 Jul; 10(14):1645-1648. PubMed ID: 29957045
    [No Abstract]   [Full Text] [Related]  

  • 12. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence and big data facilitated targeted drug discovery.
    Liu B; He H; Luo H; Zhang T; Jiang J
    Stroke Vasc Neurol; 2019 Dec; 4(4):206-213. PubMed ID: 32030204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
    Griffen EJ; Dossetter AG; Leach AG; Montague S
    Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel worlds of public and commercial bioactive chemistry data.
    Lipinski CA; Litterman NK; Southan C; Williams AJ; Clark AM; Ekins S
    J Med Chem; 2015 Mar; 58(5):2068-76. PubMed ID: 25415348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do medicinal chemists actually make? A 50-year retrospective.
    Walters WP; Green J; Weiss JR; Murcko MA
    J Med Chem; 2011 Oct; 54(19):6405-16. PubMed ID: 21755928
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of 2D fingerprints for scaffold hopping.
    Gardiner EJ; Holliday JD; O'Dowd C; Willett P
    Future Med Chem; 2011 Mar; 3(4):405-14. PubMed ID: 21452977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filtering databases and chemical libraries.
    Charifson PS; Walters WP
    Mol Divers; 2002; 5(4):185-97. PubMed ID: 12549671
    [No Abstract]   [Full Text] [Related]  

  • 19. SAR Matrix Method for Large-Scale Analysis of Compound Structure-Activity Relationships and Exploration of Multitarget Activity Spaces.
    Hu Y; Bajorath J
    Methods Mol Biol; 2018; 1825():339-352. PubMed ID: 30334212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico techniques for the identification of bioisosteric replacements for drug design.
    Devereux M; Popelier PL
    Curr Top Med Chem; 2010; 10(6):657-68. PubMed ID: 20337588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.